Study S002681

Evaluation of the Feasability of a Care Pathway Integrating Collaborative Tele-expertise for the Prevention of Recurrent Hospitalisations for Patients With Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04769765
Acronym: TELXCODIA
Study type: INTERVENTIONAL
Masking: NONE
Status: TERMINATED
Enrollment: 200
Start: 2022-05-04
Primary completion: 2022-10-10
Lead sponsor: Centre Hospitalier Universitaire de Nīmes
Conditions: Diabetes Mellitus
Interventions: OTHER:Definition of the Individualized Care Pathway
Results posted: FALSE

Registered primary outcomes

Number of patients eligible for the Individualized Care Pathway as well as the basic diabetic program. [At the end of the study period: Month 12 + 5 days]
Number of patients on the basic diabetic program, included in the study, who have completed at least three of the four scheduled follow-up visits. [At the end of the study period: Month 12 + 5 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.